NEWS RELEASE | Tuesday, December 17th, 2019
Camarico Investment Group Ltd. (CSE: CIG) ("Company") is pleased to announce that FamliFarms Ltd. (“FamliFarms”) has received a hemp cultivation licence from Health Canada for the authorized activities:
FamliFarms intends to develop high CBD strains for registration as approved cultivars and commercial cultivation of flower & leaf for the CBD processing market. The company’s operations are licensed and approved on the NW 32-20-25W4M, marking the initiation of Phase II of the Georgetown development.
FamliFarms will be working in conjunction with Camarico Land & Development, Camarico Construction and Aggro Manufacturing for the Engineering, Procurement and Construction of a modular test facility to initiate operations for registering approved cultivators and regional area development plan for Georgetown’s Phase II.
FamliFarms intends to capitalize the modular test facilities and initial operations through third party revenue sharing agreements.